The changing epidemiology of human monkeypox—A potential threat? A systematic review

Summary

Monkeypox, a zoonotic disease caused by an orthopoxvirus, results in a smallpox-like disease in humans. Since monkeypox in humans was initially diagnosed in 1970 in the Democratic Republic of the Congo (DRC), it has spread to other regions of Africa (primarily West and Central), and cases outside Africa have emerged in recent years. We conducted a systematic review of peer-reviewed and grey literature on how monkeypox epidemiology has evolved, with particular emphasis on the number of confirmed, probable, and/or possible cases, age at presentation, mortality, and geographical spread. The review is registered with PROSPERO (CRD42020208269). We identified 48 peer-reviewed articles and 18 grey literature sources for data extraction. The number of human monkeypox cases has been on the rise since the 1970s, with the most dramatic increases occurring in the DRC. The median age at presentation has increased from 4 (1970s) to 21 years (2010–2019). There was an overall case fatality rate of 8.7%, with a significant difference between clades—Central African 10.6% (95% CI: 8.4%– 13.3%) vs. West African 3.6% (95% CI: 1.7%– 6.8%). Since 2003, import- and travel-related spread outside of Africa has occasionally resulted in outbreaks. Interactions/activities with infected animals or individuals are risk behaviors associated with acquiring monkeypox. Our review shows an escalation of monkeypox cases, especially in the highly endemic DRC, a spread to other countries, and a growing median age from young children to young adults. These findings may be related to the cessation of smallpox vaccination, which provided some cross-protection against monkeypox, leading to increased human-to-human transmission. The appearance of outbreaks beyond Africa highlights the global relevance of the disease. Increased surveillance and detection of monkeypox cases are essential tools for understanding the continuously changing epidemiology of this resurging disease.

Related articles

• Shoulder Kinematic and Muscle Activity Compensations to Scapular Stabilizer Weakness: An Optimal Control Framework

  This original article explores the impact of scapular stabilizer muscle weakness on shoulder kinematics and muscle activity through an optimal control framework using computational musculoskeletal models. It aims to identify compensation mechanisms and predict kinematic changes associated with reduced muscle force-generating capacity.

• A study evaluating differences in 3D upper limb kinematics and surface electromyography measures in adults with and without facioscapulohumeral dystrophy

  This study explores the differences in three-dimensional upper limb movement and muscle activity measured through electromyography in adults diagnosed with facioscapulohumeral dystrophy (FSHD) compared to age- and sex-matched controls. It aims to enhance understanding of how FSHD affects arm function and movement.

• Relationship between glenohumeral horizontal abduction angle and scapular internal rotation angle at maximum shoulder external rotation during baseball pitching

  This study examines the relationships between the glenohumeral horizontal adduction angle and scapular internal rotation angles at maximum external rotation (MER) during baseball pitching, highlighting implications for preventing internal impingement in asymptomatic collegiate pitchers.

• PHARMACEUTICAL TOXICOLOGY

  This document provides a comprehensive overview of pharmaceutical toxicology, including concepts such as toxicity, poison, intoxication, and various areas of toxicology. It discusses the historical context of toxicology, risk assessment, types of toxicologists, and factors affecting poisoning.

• Partnership, Collaboration, and Teamwork in Nursing

  This document explores the concepts and principles of partnership, collaboration, and teamwork in the context of healthcare, emphasizing the developmental stages from self-awareness to effective interdisciplinary teamwork.